Rexford Industrial and Pfizer offer long-term value despite current market pessimism.

Rexford Industrial Realty benefits from limited supply in Southern California, steady rent growth, and disciplined management, trading below its historical valuation. Pfizer faces challenges from patent expirations but is rebuilding its drug pipeline through acquisitions and maintains a strong balance sheet with a 6.3% dividend yield. Both stocks present attractive risk and reward opportunities for patient investors as market pessimism creates favorable entry points.